GSA Capital Partners LLP Trims Stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

GSA Capital Partners LLP reduced its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 59.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,345 shares of the company's stock after selling 13,625 shares during the period. GSA Capital Partners LLP's holdings in Establishment Labs were worth $404,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Kornitzer Capital Management Inc. KS raised its holdings in shares of Establishment Labs by 2.5% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 248,435 shares of the company's stock worth $10,750,000 after acquiring an additional 6,050 shares during the period. Rice Hall James & Associates LLC grew its stake in shares of Establishment Labs by 10.7% in the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company's stock valued at $34,326,000 after buying an additional 76,959 shares during the period. SkyView Investment Advisors LLC acquired a new stake in shares of Establishment Labs during the 2nd quarter worth approximately $418,000. Lighthouse Investment Partners LLC lifted its holdings in Establishment Labs by 191.2% in the second quarter. Lighthouse Investment Partners LLC now owns 42,702 shares of the company's stock valued at $1,940,000 after acquiring an additional 28,038 shares during the last quarter. Finally, Millennium Management LLC grew its position in Establishment Labs by 49.8% in the second quarter. Millennium Management LLC now owns 273,605 shares of the company's stock worth $12,433,000 after acquiring an additional 90,943 shares during the period. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Stock Up 1.1 %

Establishment Labs stock traded up $0.47 during trading on Friday, reaching $43.08. The stock had a trading volume of 276,371 shares, compared to its average volume of 389,543. Establishment Labs Holdings Inc. has a 52-week low of $22.05 and a 52-week high of $60.12. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The stock has a market cap of $1.21 billion, a PE ratio of -16.57 and a beta of 1.20. The business has a 50 day moving average price of $42.97 and a 200 day moving average price of $45.31.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on ESTA. Stephens reiterated an "overweight" rating and set a $68.00 price target on shares of Establishment Labs in a report on Wednesday, August 7th. BTIG Research upped their price objective on shares of Establishment Labs from $62.00 to $65.00 and gave the stock a "buy" rating in a report on Monday, October 14th. JPMorgan Chase & Co. dropped their target price on shares of Establishment Labs from $61.00 to $50.00 and set an "overweight" rating for the company in a report on Wednesday, August 7th. Finally, Citigroup raised their price target on Establishment Labs from $45.00 to $50.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Establishment Labs currently has an average rating of "Moderate Buy" and an average price target of $60.60.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.